The mRNA expression levels of RGS16, SNAI1, CDR2L, FRMD5, and FSTL3 were higher in tumor samples than that in adjacent normal tissues in TCGA-COAD cohort (Figure 7(a)), suggesting that these five key genes participate in the progression of CC. This evidence concerns the gene CDR2L and neoplasm.